Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Pisters

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 6, 2007
Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vaterSunil Krishnan, Vishal Rana, Douglas B Evans, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2012
Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinomaShaofan Weng, Hua Wang, Weihong Chen, et al.
Cancer|May 12, 2007
Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control studyManal M Hassan, James L Abbruzzese, Melissa L Bondy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancerDonghui Li, Maha Ahmed, Yanan Li, et al.
Carcinogenesis|July 1, 2005
Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancerDonghui Li, Li Jiao, Yanan Li, et al.
Histopathology|October 12, 2013
Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinomaDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
The American Journal of Gastroenterology|September 4, 2007
Risk factors for pancreatic cancer: case-control studyManal M Hassan, Melissa L Bondy, Robert A Wolff, et al.
The American Journal of Surgical Pathology|February 4, 2012
Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomyDeyali Chatterjee, Asif Rashid, Hua Wang, et al.
Annals of Surgical Oncology|August 30, 2008
Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery aloneYerko Borghero, Christopher H Crane, Janio Szklaruk, et al.
Cancer|September 1, 2006
Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinomaPooja R Rohatgi, Paul F Mansfield, Christopher H Crane, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|November 6, 2007
Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vaterSunil Krishnan, Vishal Rana, Douglas B Evans, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2012
Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinomaShaofan Weng, Hua Wang, Weihong Chen, et al.
Cancer|May 12, 2007
Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control studyManal M Hassan, James L Abbruzzese, Melissa L Bondy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancerDonghui Li, Maha Ahmed, Yanan Li, et al.
Carcinogenesis|July 1, 2005
Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancerDonghui Li, Li Jiao, Yanan Li, et al.
Histopathology|October 12, 2013
Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinomaDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
The American Journal of Gastroenterology|September 4, 2007
Risk factors for pancreatic cancer: case-control studyManal M Hassan, Melissa L Bondy, Robert A Wolff, et al.
The American Journal of Surgical Pathology|February 4, 2012
Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomyDeyali Chatterjee, Asif Rashid, Hua Wang, et al.
Annals of Surgical Oncology|August 30, 2008
Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery aloneYerko Borghero, Christopher H Crane, Janio Szklaruk, et al.
Cancer|September 1, 2006
Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinomaPooja R Rohatgi, Paul F Mansfield, Christopher H Crane, et al.
Pageof 3